BIOGEN INC. (BIIB) Earnings
BIOGEN INC.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 29, 2026
From the latest earnings 8-K
Revenue · FY2025
$9.89B
▲ 2.2%YoY
Diluted EPS · FY2025
$8.79
▼ 21.4%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from BIIB's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $9.89B | $1.29B | — | $8.79 |
| FY2024 | $9.68B | $1.63B | — | $11.18 |
| FY2023 | $9.84B | $1.16B | — | $7.97 |
| FY2022 | $10.17B | $2.96B | — | $20.87 |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 29, 2026 | 8-K (2.02) | 0000875045-26-000073EDGAR |
| Jul 1, 2026 | 8-K (2.02) | 0000875045-26-000068EDGAR |
| Apr 29, 2026 | 8-K (2.02) | 0000875045-26-000042EDGAR |
| Apr 6, 2026 | 8-K (2.02) | 0000875045-26-000039EDGAR |
| Feb 6, 2026 | 8-K (2.02) | 0000875045-26-000011EDGAR |
| Jan 14, 2026 | 8-K (2.02) | 0000875045-26-000003EDGAR |
| Oct 30, 2025 | 8-K (2.02) | 0000875045-25-000047EDGAR |
| Oct 14, 2025 | 8-K (2.02) | 0000875045-25-000040EDGAR |
Never miss a BIIB filing.
Get an email when BIIB files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.